Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Balance, value at Oct. 31, 2021 $ 34,767 $ 301 $ 239,927 $ (204,790) $ 35,438 $ (671)
Balance, shares at Oct. 31, 2021   30,050,894        
Stock option compensation to employees and directors 3,598 3,598 3,598
Common stock issued upon exercise of stock options and warrants
Common stock issued upon exercise of stock options and warrants, shares   81,425        
Common stock issued to consultants 64 $ 1 63 64
Common stock issued to consultants, shares   20,000        
Common stock issued pursuant to employee stock purchase plan 7 7 7
Common stock issued pursuant to employee stock purchase plan, shares   2,389        
Net loss (7,467) (7,373) (7,373) (94)
Balance, value at Apr. 30, 2022 31,406 $ 302 244,032 (212,163) 32,171 (765)
Balance, shares at Apr. 30, 2022   30,154,708        
Stock options and warrants issued to consultants 437 437 437
Balance, value at Jan. 31, 2022 33,242 $ 301 242,281 (208,619) 33,963 (721)
Balance, shares at Jan. 31, 2022   30,132,319        
Stock option compensation to employees and directors 1,462 1,462 1,462
Stock options issued to consultants 219 219 219
Common stock issued to consultants 64 $ 1 63 64
Common stock issued to consultants, shares   20,000        
Common stock issued pursuant to employee stock purchase plan 7 7 7
Common stock issued pursuant to employee stock purchase plan, shares   2,389        
Net loss (3,588) (3,544) (3,544) (44)
Balance, value at Apr. 30, 2022 31,406 $ 302 244,032 (212,163) 32,171 (765)
Balance, shares at Apr. 30, 2022   30,154,708        
Balance, value at Oct. 31, 2022 28,200 $ 309 247,123 (218,385) 29,047 (847)
Balance, shares at Oct. 31, 2022   30,913,902        
Stock option compensation to employees and directors 2,112 2,112 2,112
Stock options issued to consultants 128 128 128
Common stock issued upon exercise of stock options and warrants 78 $ 1 77 78
Common stock issued upon exercise of stock options and warrants, shares   29,382        
Common stock issued to consultants 50 50 50
Common stock issued to consultants, shares   13,478        
Common stock issued pursuant to employee stock purchase plan 6 6 6
Common stock issued pursuant to employee stock purchase plan, shares   1,903        
Net loss (4,661) (4,610) (4,610) (51)
Balance, value at Apr. 30, 2023 25,913 $ 310 249,496 (222,995) 26,811 (898)
Balance, shares at Apr. 30, 2023   30,958,665        
Balance, value at Jan. 31, 2023 26,912 $ 309 248,189 (220,707) 27,791 (879)
Balance, shares at Jan. 31, 2023   30,922,830        
Stock option compensation to employees and directors 1,155 1,155 1,155
Stock options issued to consultants 47 47 47
Common stock issued upon exercise of stock options and warrants 75 $ 1 74 75
Common stock issued upon exercise of stock options and warrants, shares   27,818        
Common stock issued to consultants 25 25 25
Common stock issued to consultants, shares   6,114        
Common stock issued pursuant to employee stock purchase plan 6 6 6
Common stock issued pursuant to employee stock purchase plan, shares   1,903        
Net loss (2,307) (2,288) (2,288) (19)
Balance, value at Apr. 30, 2023 $ 25,913 $ 310 $ 249,496 $ (222,995) $ 26,811 $ (898)
Balance, shares at Apr. 30, 2023   30,958,665